中文 | English
Return
Total: 12 , 1/2
Show Home Prev Next End page: GO
Author:(Guofang HUANG)

1.Advances in the study of antitumor activities of the marine mollusks extracts

Fangfang HUANG ; Yongfang YANG ; Guofang DING

Journal of China Pharmaceutical University 2009;40(3):284-288

2.Regulation and control of bone marrow stromal cell differentiation towards chondrocytes

Yue HUANG ; Xudong WANG ; Guofang SHEN

Chinese Journal of Tissue Engineering Research 2009;13(6):1196-1200

3.Isolation and purification of an anticancer activity peptide from protein hydrolysate of Mytilus coruscus

Yongfang YANG ; Haiqiang YAN ; Guofang DING ; Fangfang HUANG

Journal of China Pharmaceutical University 2011;42(3):272-275

4.Effect of CYP2C19 Genetic Polymorphism on Lansoprazole Pharmacokinetics:A Systematic Review

Yi LIU ; Lin JIA ; Jing HUANG ; Guofang XU ; Yuan ZHOU ; Xiaolei REN ; Chunyan ZHANG ; Wanyu FENG

China Pharmacy 2016;27(21):2933-2936

5.Research Progress in Drug Interactions of Haloperidol

Kai LEI ; Yuan HUANG ; Si ZHANG ; Guofang HE ; Dong LIU ; Xiuhua REN

China Pharmacist 2017;20(2):334-337

6.Determination of three organic acids in Schisandrae Chinensis Fructus by HPLC.

Li LI ; Yongqing XIAO ; Dingrong YU ; Yinlian MA ; Wenqian HUANG ; Guofang TIAN ; Liang CHEN

China Journal of Chinese Materia Medica 2011;36(23):3286-3289

7.Supplementing pelvic floor muscle training with attention training can more effectively relieve women′s stress urinary incontinence

Yanping LIU ; Yanjun HOU ; Jiamin CHEN ; Guofang HUANG

Chinese Journal of Physical Medicine and Rehabilitation 2023;45(1):48-52

8.Update on the safety of antithyroid drugs during pregnancy and lactation

Hui HUANG ; Guofang CHEN ; Chao LIU

Chinese Journal of Endocrinology and Metabolism 2018;34(8):634-637

9.Anti-obesity drugs promoting energy expenditure: choices and challenges

Wenbin HUANG ; Zhiwei HE ; Xingjia LI ; Shuhang XU ; Guofang CHEN ; Chao LIU

Chinese Journal of Endocrinology and Metabolism 2023;39(11):978-981

10.Cinepazide maleate injection reduced the disability rate for acute ischemic stroke patients: a multicenter, randomized, double-blind, parallel-group, placebo-controlled phase Ⅳ clinical trial

Jun NI ; Huisheng CHEN ; Guofang CHEN ; Yong JI ; Fei YI ; Zhuobo ZHANG ; Yi YANG ; Jin WU ; Xueli CAI ; Bei SHAO ; Jianfeng WANG ; Yafang LIU ; Deqin GENG ; Xinhui QU ; Xiaohong LI ; Yan WEI ; Jianping DING ; Hua LYU ; Yining HUANG ; Yonghua HUANG ; Bo XIAO ; Tao GONG ; Liying CUI

Chinese Journal of Neurology 2020;53(10):790-797

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 12 , 1/2 Show Home Prev Next End page: GO